Loading…
Genprex, Inc. is projected to decline to $0.6825 by 2027, a -12% move from its current price of $0.7763. GNPX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.7474 | $0.7762 | $0.8061 | -0.01% |
| May 30 | $0.7357 | $0.7761 | $0.8187 | -0.03% |
| May 31 | $0.7268 | $0.776 | $0.8285 | -0.04% |
| Jun 1 | $0.7194 | $0.7759 | $0.8369 | -0.05% |
| Jun 2 | $0.7129 | $0.7758 | $0.8443 | -0.06% |
| Jun 3 | $0.7071 | $0.7757 | $0.851 | -0.08% |
| Jun 4 | $0.7018 | $0.7756 | $0.8572 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7018 | $0.7756 | $0.8572 | -0.09% |
| Week 2 | $0.6727 | $0.7749 | $0.8927 | -0.18% |
| Week 3 | $0.651 | $0.7742 | $0.9207 | -0.27% |
| Week 4 | $0.6332 | $0.7735 | $0.9448 | -0.36% |
| Week 5 | $0.6179 | $0.7728 | $0.9665 | -0.45% |
| Week 6 | $0.6043 | $0.7721 | $0.9865 | -0.54% |
| Week 7 | $0.592 | $0.7714 | $1.01 | -0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.
The lead product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Genprex was incorporated in 2009 and is based in Austin, Texas.
Genprex, Inc. (GNPX) is a healthcare stock with a current price of $0.8211 and a market cap of $8.69M. It is ranked 5188 by market capitalization among listed assets.
A major floor 45.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.6% away) — a key level to hold.
The nearest ceiling, 67.5% above — a clean break opens room to run.
A major ceiling 286.4% above — clearing it would confirm fresh momentum.
Key GNPX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GNPX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7948 | Sell | $0.7922 | Sell |
| MA 10 | $0.8109 | Sell | $0.8126 | Sell |
| MA 20 | $0.8498 | Sell | $0.8822 | Sell |
| MA 50 | $1.22 | Sell | $1.22 | Sell |
| MA 100 | $1.72 | Sell | $2.21 | Sell |
| MA 200 | $4.74 | Sell | $9.41 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 28.34 | Buy |
| Stoch RSI (14) | 49.97 | Neutral |
| CCI (20) | -115.49 | Sell |
| Williams %R (14) | -95.92 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -10.80 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 4.08 | Buy |
| TRIX (15) | -1.81 | Sell |
| Awesome (5,34) | -0.17 | Sell |
| Ultimate (7,14,28) | 27.67 | Buy |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.79 | Sell |
| ADX (14) | 43.62 | Sell |
| ATR (14) | 0.03 | Info |
The near-term technical picture is neutral, with RSI14 at 30. The stock trades with the SMA50 at $1.27 and the SMA200 at $4.84, indicating relative weakness versus its shorter- and longer-term averages. Support sits at $0.788 and resistance at $1.30, framing a potential move within a tight range.
The 30-day trading range spans from $0.64 to $1.05, suggesting a narrow window for price movement in the immediate term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.772 | $0.7763 | $1.07 | 0% | Neutral | |
| $0.5211 | $0.6825 | $0.9579 | -12% | Neutral | |
| $0.5093 | $0.6937 | $1.02 | -11% | Neutral | |
| $0.5383 | $0.7581 | $1.16 | -2% | Neutral | |
| $0.5758 | $0.8354 | $1.31 | +8% | Neutral | |
| $0.6762 | $1.01 | $1.63 | +30% | Bullish | |
| $0.6282 | $0.9613 | $1.59 | +24% | Bullish | |
| $0.5778 | $0.9062 | $1.53 | +17% | Neutral | |
| $0.6205 | $0.9964 | $1.72 | +28% | Bullish | |
| $0.5338 | $0.8768 | $1.54 | +13% | Neutral | |
| $0.7154 | $1.31 | $2.48 | +68% | Bullish | |
| $0.9467 | $2.10 | $4.43 | +170% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.772 | $0.7763 | $0.9093 | +0.00% |
| June 2026 | $0.6267 | $0.7421 | $0.9043 | -4.40% |
| July 2026 | $0.6402 | $0.7672 | $0.9522 | +3.38% |
| August 2026 | $0.6518 | $0.7883 | $0.9922 | +2.75% |
| September 2026 | $0.6338 | $0.7724 | $0.9833 | -2.02% |
| October 2026 | $0.6403 | $0.7858 | $1.01 | +1.74% |
| November 2026 | $0.6698 | $0.8273 | $1.07 | +5.27% |
| December 2026 | $0.6604 | $0.8205 | $1.07 | -0.82% |
Click any year to see its month-by-month GNPX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GNPX could reach as high as $1.07, with a base case around $0.7763 and support toward $0.772 — roughly 0% from $0.7763. Price action looks broadly range-bound.
Expect GNPX to range from $0.5211 to $0.9579 through 2027. The $0.6825 average target implies a -12% move from current prices. That is -12% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The GNPX price prediction for 2028 points to an average of $0.6937 (low $0.5093, high $1.02) — a potential decline of -11% on today's $0.7763. Price action looks broadly range-bound.
In 2029, GNPX is projected to trade between $0.5383 and $1.16, averaging $0.7581 — a potential decline of -2% from today's $0.7763. That is up +9% on the projected 2028 average. A consolidation phase looks the most probable path here.
Genprex, Inc.'s 2030 outlook centres on $0.8354, within a $0.5758 to $1.31 range. That is up +10% on the projected 2029 average. That marks a +8% change versus current levels. Price action looks broadly range-bound.
By 2031, GNPX could reach as high as $1.63, with a base case around $1.01 and support toward $0.6762 — roughly +30% from $0.7763. Buyers look set to stay in control over this stretch.
Expect GNPX to range from $0.6282 to $1.59 through 2032. The $0.9613 average target implies a +24% move from current prices. That is -5% versus the projected 2031 average. Momentum favours further upside here.
The GNPX price prediction for 2033 points to an average of $0.9062 (low $0.5778, high $1.53) — a potential gain of +17% on today's $0.7763. A consolidation phase looks the most probable path here.
In 2034, GNPX is projected to trade between $0.6205 and $1.72, averaging $0.9964 — a potential gain of +28% from today's $0.7763. That is up +10% on the projected 2033 average. Momentum favours further upside here.
Genprex, Inc.'s 2035 outlook centres on $0.8768, within a $0.5338 to $1.54 range. That is -12% versus the projected 2034 average. That marks a +13% change versus current levels. A consolidation phase looks the most probable path here.
By 2040, GNPX could reach as high as $2.48, with a base case around $1.31 and support toward $0.7154 — roughly +68% from $0.7763. Momentum favours further upside here.
Expect GNPX to range from $0.9467 to $4.43 through 2050. The $2.10 average target implies a +170% move from current prices. That is up +60% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GNPX today (≈ 1,288.161793 GNPX) could be worth
$2,698.85
+$1,698.85 (+170%) by 2050 · US Dollar
Based on the average projected GNPX price of $2.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GNPXwould be worth at today's price.
$1,000 invested in GNPX on May 27, 2025 (≈ 73.800737 GNPX) would be worth
$57.29
-$942.71 (-94.3%) today · 0.06× · US Dollar
Based on a GNPX entry price of $13.55 vs. today's $0.7763.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.79 | $982.66 | -1.7% |
| 1 month ago | $0.93 | $834.73 | -16.5% |
| 3 months ago | $2.13 | $364.46 | -63.6% |
| 6 months ago | $2.96 | $262.26 | -73.8% |
| 1 year ago | $13.55 | $57.29 | -94.3% |
| All time (5.0y) ago | $7,540 | $0.1 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GNPX forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $16.94M
Multi-year forecasts show a path of gradual upside with notable bullish years. The 2026 forecast places the average at $0.8211 with a min of $0.788 and a max of $1.13, and a neutral sentiment for the year. By 2030, the average is $0.8877 with an ROI of 8.1 and a bullish-to-neutral mix in sentiment.
In 2031 the average rises to $1.07 with an ROI of 30.1 and a bullish outlook, followed by 2032 at $1.01 (ROI 23.2) and 2034 at $1.06 (ROI 28.9). The forecast continues with 2040 averaging $1.39 (ROI 69.2) and 2050 averaging $2.20 (ROI 168.1), both labeled bullish. These figures imply meaningful upside over the long term, tempered by considerable volatility implied by an annualized volatility of 70%.
The projections are estimates, not guarantees, and carry inherent uncertainty given the early-stage nature of the company’s programs.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.8877 with an ROI of 8.1 and a bullish outlook.
Near term is neutral for 2026 with a 30-day range and volatility; longer-term forecasts show bullish years (2031, 2032, 2034, 2040, 2050) with rising averages, but these are estimates and not guarantees.
Yes. The 2026 forecast has a max of $1.13, with an average of $0.8211 and a min of $0.788.
The 2050 forecast shows an average price of $2.20 with a max of $4.66 and a min of $0.9944, and an ROI of 168.1, with a bullish sentiment.
The 2031 forecast shows an average price of $1.07 with a min of $0.716, a max of $1.73, and an ROI of 30.1, with a bullish sentiment.
Genprex, Inc. Community Discussion
0Share your Genprex, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.